• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Denileukin Diftitox

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic Area Biomarker  Label Sections with
Pharmacogenomic
Information
Denileukin Diftitox Oncology CD25 Indications and Usage
Warnings and Precautions
Clinical Studies

 

back to Table of Pharmacogenomic Biomarkers in Drug Labels

-
-